MARKETS
Markets

Lifeward Appoints Josh Hexter As Interim CEO, Succeeding Mark Grant, Effective September 1; Names Rami Aviram CFO Effective November 1

Aug 31, 2026 · 04:17 PM ET· updated 2h ago

Lifeward Ltd. (NASDAQ:LFWD) ("Lifeward" or the "Company"), a diversified biomedical innovation company with a portfolio of commercialized neurorehabilitation products and a biomedical pipeline, today

Share
Why It Matters

Lifeward is getting new leaders: a new CEO starting September 1st and a new money-manager starting November 1st. When a company makes big leadership changes, it's worth watching to see if the new team makes smart decisions and if people stay confident in the company.

This read is generated by AI from raw market data and is for education only. It is not financial advice, not a signal, and not a recommendation to buy or sell.
Tickers in Play

Last session drawn · prints held ~15 minutes · licensed exchange data

Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.

Disclosure: Educational and informational purposes only — not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.